Tüdőrák: nyitott vizsgálatok itt: Franciaország
315 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. nov. 10.. Ask the study team whether a trial fits you.
3. fázisToborzás még nem indultResearch participation
A Study of Ivonescimab Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants with Unresectable Stage III NSCLC
- Where
- Amiens, Caen Cedex 5, Créteil, Limoges, Montpellier Cedex 5, Paris, Rennes Cedex 9, Villejuif
- Age
- 18 év and over
- People
- 95 worldwide
- Run by
- Summit Therapeutics Inc.
See details and how to join2026-526300-67-00EU 2026-526300-67-00Regiszter frissítve: 2026-11-09
No phaseToborozTrial-stage medicine
Analysis of Circulating Tumor Markers in Blood
- Where
- Montpellier
- Age
- 18 év and over
- People
- 992
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
See details and how to joinNCT04025541Regiszter frissítve: 2026-11-09
3. fázisToborozTrial-stage medicine
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
- Where
- Avignon, Bayonne, Bordeaux Cedex, Brest Cedex 2, Dijon, Le Mans Cedex 9, Lille, Marseille, Paris, Pierre-Bénite, Toulon, Toulouse, Vandoeuvre Les Nancy Cedex
- Age
- 18 év and over
- People
- 1000 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06561386EU 2024-513682-40-01Regiszter frissítve: 2026-11-09
3. fázisToborozTrial-stage medicine
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Where
- Caen, Lille, Lyon, Paris Cedex 13, Saint-Herblain Cedex, Tours, Villejuif
- Age
- 18 év and over
- People
- 680 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06623422EU 2023-506327-29-00Regiszter frissítve: 2026-11-09
1/2. fázisToborozTrial-stage medicine
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
- Where
- Brest, Bron, Grenoble Cedex 9, Limoges
- Age
- 18 év to 64 év
- People
- 170 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07227597EU 2025-521032-11-00Regiszter frissítve: 2026-11-09
2. fázisToborozTrial-stage medicine
Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab
- Where
- Lyon, Paris
- Age
- 18 év and over
- People
- 60 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07486817EU 2025-523567-38-00Regiszter frissítve: 2026-11-09
3. fázisToborozTrial-stage medicine
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
- Where
- Clermont-Ferrand, Dijon, Paris, Pessac, Rennes, Suresnes, Toulouse, Vandoeuvre Les Nancy
- Age
- 18 év and over
- People
- 876 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07513376EU 2025-522643-18-00Regiszter frissítve: 2026-11-09
3. fázisToborozTrial-stage medicine
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
- Where
- Avignon, Bron, Caen Cedex 5, Clermont Ferrand Cedex 1, Lyon, Montpellier Cedex 5, Quimper Cedex, Reims Cedex, Saint-Herblain, Strasbourg Cedex, Suresnes, Villejuif
- Age
- 18 év and over
- People
- 400 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07541170EU 2025-524263-21-01Regiszter frissítve: 2026-11-09
3. fázisToborozTrial-stage medicine
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
- Where
- Avignon Cedex 9, Boulogne-Billancourt, Bron, Caen Cedex 5, Caen Cedex 9, Créteil, Dijon, Le Mans Cedex 9, Lyon, Lyon Cedex 04, Marseille, Nice Cedex 2, Paris, Pessac, Pierre-Bénite, Quimper Cedex, Rennes, Saint-Herblain, Saint-Herblain Cedex, Suresnes, Valenciennes, Villefranche Sur Saone Cedex, Villejuif
- Age
- 18 év and over
- People
- 356 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07566052EU 2025-524079-22-00Regiszter frissítve: 2026-11-09
1/2. fázisToborozTrial-stage medicine
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Where
- Lyon, Saint-Herblain, Toulouse Cedex 9, Villejuif
- Age
- 12 év and over
- People
- 840 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05384626EU 2024-514266-39-00Regiszter frissítve: 2026-11-06
3. fázisToborozTrial-stage medicine
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Where
- Bayonne, Besancon Cedex, Boulogne-Billancourt, Brest, Caen Cedex 9, Chambéry, Créteil, La Roche Sur Yon Cedex 9, Le Mans Cedex 9, Lille, Marseille, Montpellier, Nantes Cedex 2, Nice Cedex 2, Nîmes, Orleans Cedex 2, Paris, Paris Cedex 14, Paris Cedex 20, Pessac, Poitiers, Quimper Cedex, Reims Cedex, Rennes, Rouen Cedex, Saint-Grégoire, Saint-Priest-en-Jarez, Strasbourg Cedex, Toulon Cedex 9, Toulouse, Toulouse Cedex 3, Tours Cedex 9, Villefranche sur Saône, Villejuif
- Age
- 18 év to 100 év
- People
- 750 worldwide
- Run by
- Amgen
See details and how to joinNCT05920356EU 2022-501863-41-00Regiszter frissítve: 2026-11-06
3. fázisToborozTrial-stage medicine
A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.
- Where
- Angers, Bordeaux, Le Mans Cedex 9, Lyon, Vantoux
- Age
- 18 év and over
- People
- 290 worldwide
- Run by
- ETOP IBCSG Partners Foundation
See details and how to joinNCT06284317EU 2023-508773-82-00Regiszter frissítve: 2026-11-06
3. fázisToborozTrial-stage medicine
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- Where
- Bordeaux, Brest, Bron, Creteil Cedex, Grenoble Cedex 9, Lille, Lyon, Marseille, Montpellier Cedex 5, Paris, Paris Cedex 18, Rennes Cedex 9, Saint-Herblain, Saint-Herblain Cedex, Strasbourg Cedex, Toulouse, Villejuif
- Age
- 18 év and over
- People
- 590 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06881784EU 2024-518154-16-00Regiszter frissítve: 2026-11-06
No phaseToborozTrial-stage medicine
Analysis of Circulating Tumor Markers in Blood - ALCINA 5
- Where
- Montpellier
- Age
- 18 év and over
- People
- 620
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
See details and how to joinNCT07060950Regiszter frissítve: 2026-11-06
No phaseToborozTrial-stage medicine
Development of Clinical and Biological Database on Bronchial Cancer
- Where
- Montpellier
- Age
- 18 év and over
- People
- 750
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
See details and how to joinNCT07085429Regiszter frissítve: 2026-11-06
2. fázisToborozTrial-stage medicine
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
- Where
- Bordeaux, Dijon, Lyon, Paris, Suresnes
- Age
- 18 év and over
- People
- 105 worldwide
- Run by
- Verastem, Inc.
See details and how to joinNCT07659782EU 2026-526472-23-00Regiszter frissítve: 2026-11-06
1/2. fázisToborozTrial-stage medicine
A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
- Where
- Dijon, Marseille
- Age
- 18 év and over
- People
- 315 worldwide
- Run by
- Voronoi, Inc
See details and how to joinNCT07699328EU 2025-523122-40-00Regiszter frissítve: 2026-11-06
No phaseToborzás még nem indultResearch participation
PROMETHEE: A Shared Interregional Tele-Tobacco Cessation Platform Embedded Within the IMPULSION Lung Cancer Screening Program
- Where
- Pierre-Bénite
- Age
- 50 év to 74 év
- People
- 5400
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT07921719Regiszter frissítve: 2026-11-06
3. fázisToborozTrial-stage medicine
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Where
- Angers, Bobigny, Bron, Caen, Lyon, Montpellier, Nice, Paris, Pessac, Reims, Saint-Quentin, Strasbourg, Vannes
- Age
- 18 év and over
- People
- 600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06793215Regiszter frissítve: 2026-11-05
3. fázisToborozTrial-stage medicine
First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.
- Where
- Avignon, Caen, Creil, Lille, Lyon, Nice, Nîmes, Paris, Saint-Cloud, Tarbes, Villejuif
- Age
- 18 év and over
- People
- 124
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT06840782Regiszter frissítve: 2026-11-05
3. fázisToborozTrial-stage medicine
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
- Where
- Bordeaux, Brest, Grenoble Cedex 9, Lille, Marseille, Nantes Cedex 1, Paris, Paris Cedex 20, Rennes, Rouen, Toulouse, Villejuif
- Age
- 18 év and over
- People
- 680 worldwide
- Run by
- Pfizer
See details and how to joinNCT07144280EU 2025-521281-97-00Regiszter frissítve: 2026-11-05
3. fázisToborozTrial-stage medicine
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
- Where
- Bordeaux, Dijon, Lille, Limoges, Lyon, Marseille, Montpellier Cedex 5, Paris, Saint-Herblain, Toulouse, Villejuif
- Age
- 18 év and over
- People
- 850 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07361497EU 2025-523576-23-00Regiszter frissítve: 2026-11-05
1/2. fázisToborozTrial-stage medicine
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
- Where
- Lille, Lyon, Marseille, Saint-Herblain, Villejuif
- Age
- 18 év and over
- People
- 160 worldwide
- Run by
- TRIANA Biomedicines, Inc.
See details and how to joinNCT07491497EU 2025-524418-27-00Regiszter frissítve: 2026-11-05
1. fázisToborozTrial-stage medicine
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
- Where
- Toulouse, Villejuif
- Age
- 18 év and over
- People
- 250 worldwide
- Run by
- Pfizer
See details and how to joinNCT07519655Regiszter frissítve: 2026-11-05
1/2. fázisToborozTrial-stage medicine
A 2-part Phase 1/2 Open-label Trial on ODM-212
- Where
- Bordeaux, Marseille, Poitiers, Villejuif
- Age
- 18 év and over
- People
- 229 worldwide
- Run by
- Orion Corporation, Orion Pharma
See details and how to joinNCT07563738Regiszter frissítve: 2026-11-05
Minden vizsgálat (Tüdőrák) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.